For citations:
Dokshina I.A., Minaeva N.V., Pozdeev N.M., Fedorovskaya N.S., Ovsepyan V.A., Rylov A.V., Paramonov I.V. AZACITIDINE IS THE PREPARATION OF CHOICE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES PATIENTS. Russian journal of hematology and transfusiology. 2017;62(2):60-64. (In Russ.) https://doi.org/10.18821/0234-5730-2017-62-2-60-64